Novel Pharmaceutical Cocrystal of Voxelotor, a Hemoglobin Oxygen Affinity Modulator: Synthesis, Crystal Structure, and Physicochemical Properties
- 16 October 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 23 (11) , 8065-8075
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- Nitrofurantoin– p ‐aminobenzoic acid cocrystal: Hydration stability and dissolution rate studiesJournal of Pharmaceutical Sciences, 2011
- Crystal Polymorphism in Chemical Process DevelopmentAnnual Review of Chemical and Biomolecular Engineering, 2011
- Benefits of cocrystallisation in pharmaceutical materials science: an updateJournal of Pharmacy and Pharmacology, 2010
- The growing world of crystal formsChemical Communications, 2010
- OLEX2: a complete structure solution, refinement and analysis programJournal of Applied Crystallography, 2009
- Hirshfeld surface analysisCrystEngComm, 2008
- Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution ratesAdvanced Drug Delivery Reviews, 2007
- The Salt−Cocrystal Continuum: The Influence of Crystal Structure on Ionization StateMolecular Pharmaceutics, 2007
- Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?Chemical Communications, 2004
- Drug polymorphism and dosage form design: a practical perspectiveAdvanced Drug Delivery Reviews, 2004